386 related articles for article (PubMed ID: 26251127)
1. Urethra-sparing high-intensity focused ultrasound for localized prostate cancer: Functional and oncological outcomes.
Shoji S; Nakano M; Fujikawa H; Endo K; Hashimoto A; Tomonaga T; Terachi T; Uchida T
Int J Urol; 2015 Nov; 22(11):1043-9. PubMed ID: 26251127
[TBL] [Abstract][Full Text] [Related]
2. Editorial Comment to Urethra-sparing high-intensity focused ultrasound for localized prostate cancer: Functional and oncological outcomes.
Inamoto T; Azuma H
Int J Urol; 2015 Nov; 22(11):1050. PubMed ID: 26248507
[No Abstract] [Full Text] [Related]
3. Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients.
Crouzet S; Chapelon JY; Rouvière O; Mege-Lechevallier F; Colombel M; Tonoli-Catez H; Martin X; Gelet A
Eur Urol; 2014 May; 65(5):907-14. PubMed ID: 23669165
[TBL] [Abstract][Full Text] [Related]
4. Hemi salvage high-intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a prospective two-centre study.
Baco E; Gelet A; Crouzet S; Rud E; Rouvière O; Tonoli-Catez H; Berge V; Chapelon JY; Eggesbø HB
BJU Int; 2014 Oct; 114(4):532-40. PubMed ID: 24930692
[TBL] [Abstract][Full Text] [Related]
5. Transrectal high-intensity focused ultrasound for treatment of localized prostate cancer.
Inoue Y; Goto K; Hayashi T; Hayashi M
Int J Urol; 2011 May; 18(5):358-62. PubMed ID: 21449970
[TBL] [Abstract][Full Text] [Related]
6. Comparisons of Oncological and Functional Outcomes Between Primary Whole-Gland Cryoablation and High-Intensity Focused Ultrasound for Localized Prostate Cancer.
Liu YY; Chiang PH
Ann Surg Oncol; 2016 Jan; 23(1):328-34. PubMed ID: 26088651
[TBL] [Abstract][Full Text] [Related]
7. Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years.
Thüroff S; Chaussy C
J Urol; 2013 Aug; 190(2):702-10. PubMed ID: 23415962
[TBL] [Abstract][Full Text] [Related]
8. Morphological analysis of the effects of intraoperative transrectal compression of the prostate during high-intensity focused ultrasound for localized prostate cancer.
Shoji S; Hashimoto A; Nakamoto M; Fukuda N; Fujikawa H; Endo K; Tomonaga T; Nakano M; Terachi T; Uchida T
Int J Urol; 2015 Jun; 22(6):563-71. PubMed ID: 25808497
[TBL] [Abstract][Full Text] [Related]
9. Primary whole-gland ablation for localized prostate cancer with high-intensity focused ultrasound: The important predictors of biochemical recurrence.
Chen PY; Chiang PH; Liu YY; Chuang YC; Cheng YT
Int J Urol; 2018 Jun; 25(6):615-620. PubMed ID: 29756298
[TBL] [Abstract][Full Text] [Related]
10. Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes.
Pfeiffer D; Berger J; Gross AJ
BJU Int; 2012 Dec; 110(11):1702-7. PubMed ID: 22928703
[TBL] [Abstract][Full Text] [Related]
11. Fourteen-year oncological and functional outcomes of high-intensity focused ultrasound in localized prostate cancer.
Ganzer R; Fritsche HM; Brandtner A; Bründl J; Koch D; Wieland WF; Blana A
BJU Int; 2013 Aug; 112(3):322-9. PubMed ID: 23356910
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of proton magnetic resonance spectroscopy in predicting positive biopsy after high-intensity focused ultrasound for treatment of localized prostate cancer.
Muto S; Kaminaga T; Horiuchi A; Kitamura K; Saito K; Isotani S; Yamaguchi R; Ide H; Furui S; Horie S
Int J Urol; 2014 Aug; 21(8):776-80. PubMed ID: 24650235
[TBL] [Abstract][Full Text] [Related]
13. Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer: a multicenter study.
Uchida T; Baba S; Irie A; Soh S; Masumori N; Tsukamoto T; Nakatsu H; Fujimoto H; Kakizoe T; Ueda T; Ichikawa T; Ohta N; Kitamura T; Sumitomo M; Hayakawa M; Aoyagi T; Tachibana M; Ikeda R; Suzuki K; Tsuru N; Suzuki K; Ozono S; Fujimoto K; Hirao Y; Monden K; Nasu Y; Kumon H; Nishi K; Ueda S; Koga H; Naitoh S
Hinyokika Kiyo; 2005 Oct; 51(10):651-8. PubMed ID: 16285617
[TBL] [Abstract][Full Text] [Related]
14. Non-Whole-Gland High-Intensity Focused Ultrasound vs Whole-Gland High-Intensity Focused Ultrasound for Management of Localized Prostate Cancer: 1-Year Oncological and Functional Outcomes.
Lei Y; Zanker P; Yildiz S; Hancke K; Seidl D; Koch O; Schwentner C; Mundhenk J
J Endourol; 2019 Feb; 33(2):100-106. PubMed ID: 30526029
[TBL] [Abstract][Full Text] [Related]
15. Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissue in Patients with Localized Prostate Cancer: A Prospective Phase 1 Clinical Trial.
Chin JL; Billia M; Relle J; Roethke MC; Popeneciu IV; Kuru TH; Hatiboglu G; Mueller-Wolf MB; Motsch J; Romagnoli C; Kassam Z; Harle CC; Hafron J; Nandalur KR; Chronik BA; Burtnyk M; Schlemmer HP; Pahernik S
Eur Urol; 2016 Sep; 70(3):447-55. PubMed ID: 26777228
[TBL] [Abstract][Full Text] [Related]
16. Short-term outcome after high-intensity focused ultrasound in the treatment of patients with high-risk prostate cancer.
Ficarra V; Antoniolli SZ; Novara G; Parisi A; Fracalanza S; Martignoni G; Artibani W
BJU Int; 2006 Dec; 98(6):1193-8. PubMed ID: 17125477
[TBL] [Abstract][Full Text] [Related]
17. Improved outcomes with advancements in high intensity focused ultrasound devices for the treatment of localized prostate cancer.
Uchida T; Tomonaga T; Kim H; Nakano M; Shoji S; Nagata Y; Terachi T
J Urol; 2015 Jan; 193(1):103-10. PubMed ID: 25079940
[TBL] [Abstract][Full Text] [Related]
18. Experience with high-intensity focused ultrasound therapy for management of organ-confined prostate cancer: critical evaluation of oncologic outcomes.
Komura K; Inamoto T; Masuda H; Watsuji T; Azuma H
Acta Biomed; 2012 Dec; 83(3):189-96. PubMed ID: 23762994
[TBL] [Abstract][Full Text] [Related]
19. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience.
Blana A; Walter B; Rogenhofer S; Wieland WF
Urology; 2004 Feb; 63(2):297-300. PubMed ID: 14972475
[TBL] [Abstract][Full Text] [Related]
20. Quality of life and functional outcome after infravesical desobstruction and HIFU treatment for localized prostate cancer.
Hatiboglu G; Popeneciu IV; Deppert M; Nyarangi-Dix J; Hadaschik B; Hohenfellner M; Teber D; Pahernik S
BMC Urol; 2017 Jan; 17(1):5. PubMed ID: 28077116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]